2 recruiting, 1 not yet recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
Follow Rectal Cancers: new trials by email Literature Review of Rectal Cancers trials Research Report on Rectal Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Radiotherapy for Safe Hypofractionation Adaptive Hypofractionated Radiotherapy, Standard-of-care Radiotherapy - Cancer, Endometrial Cancer | Phase 2 | Not yet recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 264 | 2026-11-01 | 2026-10-29 |
| Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial Adalimumab+NALIRIFOX→Short course radiotherapy →Adalimumab+NALIRIFOX, Adalimumab+NALIRIFOX→Long course chemoradiotherapy →Adalimumab+NALIRIFOX - Rectal Cancers | Phase 2 | Recruiting | Sun Yat-sen University | 84 | 2026-05-26 | 2026-09-17 |
| Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma After Low Anterior Resection for Rectal Cancer methylene blue injection - Rectal Cancers | Phase 2 | Recruiting | Peking University Cancer Hospital & Institute | 26 | 2025-11-25 | 2026-09-22 |
Rectal Neoplasms (3) · Endometrial Neoplasms (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Uterine Cervical Neoplasms (1)
Colorectal Neoplasms (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Rectal Diseases (3) · Neoplasms (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1)
Methylene Blue (1)
Centre hospitalier de l'Université de Montréal (CHUM) (1) · Peking University Cancer Hospital & Institute (1) · Sun Yat-sen University (1)
China (2) · Canada (1)